Search

Your search keyword '"Pecen, Ladislav"' showing total 289 results

Search Constraints

Start Over You searched for: Author "Pecen, Ladislav" Remove constraint Author: "Pecen, Ladislav"
289 results on '"Pecen, Ladislav"'

Search Results

6. Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

7. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

8. Comparison of four routinely used vitamin D automated immunoassays

10. Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia ― One-Year Data From the Global ETNA-AF Program ―

17. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

20. Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry

22. Supplementary Data from TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

26. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

27. EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

29. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care

32. Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis

33. Vitamin D 3 Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals.

34. Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 Infection

35. The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung Tumors

37. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care

39. Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries

42. Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

47. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

48. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer

Catalog

Books, media, physical & digital resources